Nuzenio

Trevi Therapeutics Inc

Trevi Therapeutics Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 13:38:00 GMTRaymond James Sticks to Its Buy Rating for Trevi Therapeutics (TRVI) - The Globe and Mail
Sat, 08 Aug 2026 13:23:00 GMTTrevi Therapeutics (TRVI) Receives a New Rating from B. Riley Securities - The Globe and Mail
Sat, 08 Aug 2026 12:29:57 GMTQ2 2026 Trevi Therapeutics Inc Earnings Call Transcript - GuruFocus
Sat, 08 Aug 2026 07:14:59 GMTOppenheimer Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $25 - Moomoo
Fri, 07 Aug 2026 23:12:38 GMTTrevi Therapeutics (NASDAQ:TRVI) Announces Earnings Results, Hits Estimates - MarketBeat
Fri, 07 Aug 2026 18:15:45 GMTTrevi Therapeutics Q2 Earnings Call Highlights - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Trevi Therapeutics Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.